Compare NOTV & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOTV | VVOS |
|---|---|---|
| Founded | 1974 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7M | 15.1M |
| IPO Year | 1997 | 2020 |
| Metric | NOTV | VVOS |
|---|---|---|
| Price | $0.34 | $1.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.50 | ★ $6.25 |
| AVG Volume (30 Days) | ★ 549.0K | 88.8K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 49.64 | ★ 80.07 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $547,656,000.00 | $15,031,000.00 |
| Revenue This Year | $5.28 | $31.42 |
| Revenue Next Year | $5.42 | $49.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 511.19 | 8.91 |
| 52 Week Low | $0.25 | $1.28 |
| 52 Week High | $3.35 | $7.40 |
| Indicator | NOTV | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 32.01 |
| Support Level | $0.26 | N/A |
| Resistance Level | $0.65 | $1.88 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 38.75 | 6.25 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.